Moreover, it was also suggested that DEHP activates Jun-N-terminal kinase (JNK), promoting the apoptosis of hepatic cells and the inhibition of insulin sensitivity, which may lead to metabolic disorders [89,90]. This evidence concerns the gene INS and Other metabolic disease.